Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab

PURPOSE: This study was designed to evaluate the associations between angiogenesis gene polymorphisms and clinical outcome in ovarian cancer patients treated with low dose Cyclophosphamide and Bevacizumab. EXPERIMENTAL DESIGN: Seventy recurrent/metastatic epithelial ovarian cancer patients were enro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schultheis, Anne M, Lurje, Georg, Rhodes, Katrin E, Zhang, Wu, Yang, Dongyun, Garcia, Agustin A, Morgan, Robert, Gandara, David, Scudder, Sidney, Oza, Amit, Hirte, Hal, Fleming, Gini, Roman, Lynda, Lenz, Heinz-Josef
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2586993/
https://ncbi.nlm.nih.gov/pubmed/19010874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0351
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados